• The hospital campus COVID-19 vaccine clinic is now open Mondays, Tuesdays, Wednesdays and Saturdays from 7:30 a.m. to 5 p.m., due to reduced demand.
  • Up to three caregivers can now be designated as eligible visitors for each inpatient (up from two).
  • Important note: we are still only allowing TWO caregivers to visit at a time.
  • Parents/caregivers who are fully vaccinated no longer need to be tested prior to their child being admitted to a double room.

For more information, contact patientCOVIDvaccine@seattlechildrens.org.

 

In case you missed it…

  • Pediatric vaccine trials: Seattle Children’s is one of the sites for a phase 2/phase 3 study to evaluate the safety, tolerability and immunogenicity of the Pfizer COVID-19 vaccine in healthy children ages 6 months to 11 years old.  Dr. Janet Englund of Seattle Children’s Center for Clinical and Translational Research is the principal investigator.  Recruitment has been successful and additional volunteers are not needed. For more information, visit COVID-19 Vaccine Clinical Trials in Children or email IDResearch@seattlechildrens.org.
  • Updates to COVID-19 serology testing: Seattle Children’s Lab will offer antibody testing to detect immune response to natural infection and vaccine, effective June 28. This test, COVID-19 Antibody, Spike IgG is a companion to our current COVID-19 antibody, IgG (nucleocapsid) test.  Antibodies to the spike protein should be detectable after vaccination or natural infection.  Antibodies to the nucleocapsid protein are only detectable after infection.  It is not yet known how long antibodies will be detectable in blood.